Medidata Solutions
announced that South Korean contract research organization (CRO)
MediCROstar
has joined Medidata’s channel partner program for CROs and other service providers. In addition to bringing the capabilities of the
Medidata Rave
electronic data capture (EDC) and clinical data management (CDM) solution, the partnership will enable MediCROstar to further expand its presence in the APAC region and continue to build its stake in the global clinical trials marketplace.
Founded in 2006, Seoul-based MediCROstar specializes in electronic case report format (eCRF) data management and protocol development for investigator-initiated trials. With experience managing clinical trials across South Korea and India, MediCROstar executives helped the Korea Food and Drug Administration (KFDA) write formal guidance on conducting EDC trials. As a result, the company has become a player in South Korea’s clinical development as the growth in clinical trials in the region has driven increasing need for technologies as well as outsourcing organizations to help efficiently manage the studies. MediCROstar looks to the Medidata partner program as a key driver of its global expansion and is developing new services around Medidata Rave to offer customers the efficient data management, local language capabilities and ease of use of the proven Rave platform.
“The adoption of EDC technology is a growing trend in South Korea, mirroring its use in the global pharmaceutical industry, and we have looked to Medidata’s partner program to help us field the increasing demand for innovative clinical technologies,” said Inyoung Choi, director, MediCROstar.
MediCROstar expects to leverage the Medidata Rave solution for a number of Phase III global multinational trials over the next year.
On September 10th, Medidata and MediCROstar will co-host a seminar titled “Safe Transfer – From Paper CRF to eCRF” at EL Tower, 24 Yangjae-dong, Seocho-gu, Seoul, South Korea. The seminar will outline the sponsor and CRO benefits of the Medidata Rave solution and introduce trends of data management in Korea. Presenters include Dong-Seok Yim, MediCROstar CEO, and Takeru Yamamoto, head of APAC at Medidata Solutions. For more information, please visit:
www.medicrostar.com
Medidata first announced its channel partner program in April 2005 to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, the program has grown to include over 25 partners. For more information, please visit:
www.mdsol.com/partnerships/cros.htm
.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.